Anuradha Sekaran
Overview
Explore the profile of Anuradha Sekaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Idrees U, Das M, Sekaran A, Reddy D
Indian J Pathol Microbiol
. 2025 Feb;
PMID: 39918233
Plasmablastic lymphoma (PBL) is an aggressive lymphoma with the proliferation of plasmablastic cells with a plasma cell immunophenotype and immunonegativity for B-cell markers. Here we present a case of jejunal...
2.
Kadnur H, Reddy H, Wanve B, Sonowal R, Rughwani H, Sekaran A
Indian J Sex Transm Dis AIDS
. 2025 Jan;
45(2):141-143.
PMID: 39886252
In this case report, we present a 35-year-old homosexual man with advanced HIV disease and disseminated tuberculosis (TB) who developed paradoxical TB immune reconstitution inflammatory syndrome (IRIS). Corticosteroids, vital in...
3.
Katrevula A, Sekaran A, Asif S, Duvvur N
Gastrointest Endosc
. 2024 Nov;
PMID: 39492555
No abstract available.
4.
Gahra A, Katrevula A, Sekaran A, Wanve B, Katukuri G, Lakhtakia S, et al.
ACG Case Rep J
. 2024 Oct;
11(10):e01529.
PMID: 39391801
We report a case of primary enteropathy-associated T-cell lymphoma in a 50-year-old man presenting with abdominal pain, chronic diarrhea, and significant weight loss over 6 months. Diagnosis was confirmed through...
5.
Lakhtakia S, Mehrotra K, Sekaran A, Itha S, Duvvur N
Cureus
. 2024 Sep;
16(8):e67114.
PMID: 39290926
VIPomas are a rare type of functional pancreatic neuroendocrine tumors (PNETs), causing symptoms due to their hypersecretion in the gastrointestinal tract. The rare association of PNETs with tumors of endocrine...
6.
Kulkarni A, Kumaraswamy P, Menon B, Sekaran A, Rambhatla A, Iyengar S, et al.
J Liver Cancer
. 2024 May;
24(2):224-233.
PMID: 38797993
Backgrounds/aims: Hepatocellular carcinoma (HCC) is generally diagnosed at an advanced stage, which limits curative treatment options for these patients. Locoregional therapy (LRT) is the standard approach to bridge and downstage...
7.
Jagtap N, Kalapala R, Rughwani H, Singh A, Inavolu P, Ramchandani M, et al.
Indian J Gastroenterol
. 2024 May;
43(5):995-1001.
PMID: 38758433
Aims: There is limited data on the prevalence and risk factors of colonic adenoma from the Indian sub-continent. We aimed at developing a machine-learning model to optimize colonic adenoma detection...
8.
Banerjee R, Pal P, Patel R, Godbole S, Komawar A, Mudigonda S, et al.
Lancet Reg Health Southeast Asia
. 2023 Dec;
19:100259.
PMID: 38076713
Background: Traditionally, infectious diarrhoea has been the major cause of lower GI symptoms across the developing world. Increasing urbanization has been implicated for the rising IBD cases despite very limited...
9.
Ahmed Z, Patil S, Sekaran A, Rebala P, Rao G
Turk J Surg
. 2023 Dec;
39(3):190-196.
PMID: 38058374
Objectives: Indocyanine green (ICG) dye guided near infrared fluorescence (NIR) imaging is a promising tool for mapping lymphatics. The aim of this study was to evaluate the role of ICG...
10.
Vishnubhotla R, Avanthi S, Mitnala S, Guduru V, Rebala P, Patil S, et al.
Mol Carcinog
. 2023 Nov;
63(3):361-370.
PMID: 37983720
Colorectal cancer (CRC) is known to follow adenoma carcinoma sequence (ACS) in majority of the tumors and the driver variants and associated pathways are well delineated. However, most of the...